High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response

Medical Science Monitor

Volumn 10, Issue 10, 2004, Pages

  Svirshchevskaya, Elena V ^a,d   Viskova, Natalya ^a   Shevchenko, Marina ^a   Alekseeva, Ludmila ^a   Marchenko, Alexei ^b   Benevolensky, Sergei ^b   Kurup, Viswanath P ^c  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Allergy; Animal models; Aspergillus fumigatus; Specific immunotherapy; Virus like particles

Indexed keywords

ALLERGEN; ASP F2 ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL PROTECTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; RECEPTOR AFFINITY; VIRUS PARTICLE;

EID: 7044234666     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Daly P, Kavanagh K: Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci, 2001; 58: 197-205
2. Knutsen A.P, Slavin RG: Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Clin Rev Allergy, 1991; 9: 103-18
3. Wark P.A, Gibson PG: Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology, 2001; 6: 1-7
4. Marr KA, Patterson T, Denning D: Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am, 2002; 16(4): 875-94
5. Greenberger PA: Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol, 2002; 110(5): 685-92
6. Park HS, Nahm DH, Kim HY et al: Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen. Ann Allergy Asthma Immunol, 2001; 86: 444-48
7. Bahceciler NN, Isik U, Barlan IB, Basaran MM: Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol, 2001; 32: 49-55
8. Leynadier F, Banoun L, Dollois B et al: Andre: Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy, 2001; 31: 988-96
9. Oldfield W.L, Kay AB, Larche M: Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol, 2001; 167: 1734-39
10. Simons FE, Imada M, Li Y et al: Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol, 1996; 8: 1937-45
11. Ewan PW: New insight into immunological mechanisms of venom immunotherapy. Curr Opin Allergy Clin Immunol, 2001; 1: 367-74
12. Magnan A, Marin V, Mely L et al: Venom immunotherapy induces monocyte activation. Clin Exp Allergy, 2001; 31: 1303-9
13. Pajno GB, Barberio G, De Luca F et al: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy, 2001; 31: 1392-97
14. Voltolini S, Modena P, Minale P et al: Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Madr), 2001; 29: 103-10
15. Purello-D'Ambrosio F, Gangemi S, Merendino RA et al: Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy, 2001; 31: 1295-302
16. Adkinson NF Jr, Eggleston PA, Eney D et al: A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med, 1997; 336: 324-31
17. Cianferoni A, Novembre E, Mugnaini L et al: Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). Ann Allergy Asthma Immunol, 2001; 87: 27-32
18. Seitzer U, Bussler H, Kullmann B et al: Quantitative assessment of immediate cutaneous hypersensitivity in a mouse model exhibiting an IgE response to Timothy grass allergens. Med Sci Monit, 2003; 9(12): BR407-BR412
19. Novak N, Kraft S, Bieber T: IgE receptors. Curr Opin Immunol, 2001; 13: 721-26
20. Takai T, Mori A, Yuuki T et al: Non-anaphylactic combination of partially deleted fragments of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Mol Immunol, 1999; 36: 1055-65
21. Akdis CA, Blaser K: Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol, 2000; 121: 261-69
22. Tang B, Banerjee B, Greenberger PA et al: Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen. Biochem Biophys Res Commun, 2000; 270: 1128-35
23. Banerjee B, Greenberger PA, Fink JN, Kurup VP: Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun, 1999; 67: 2284-91
24. Kurup VP, Choi H, Resnick A et al: Immunopathological response of C57BL/6 and C3H/HeN mice to Aspergillus fumigatus antigens. Int Arch Allergy Appl Immunol, 1990; 91(2): 145-54
25. Parker J, Guo D, Hodges R: New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry, 1986; 25: 5425-32
26. Menndez-Arias L, Rodriguez R: A BASIC microcomputer program for prediction of B and T cell epitopes in proteins. Comput Appl Biosci, 1990; 6: 101-15
27. Sokolova EA, Starkova NN, Vorotyntseva TI, Zamolodchikova TS: A serine protease from the bovine duodenal mucosa, chymotrypsin-like duodenase. Eur J Biochem, 1998; 255(2): 501-7
28. Marchenko AN, Kozlov DG, Svirshchevskaya EV, Benevolensky SV: The p1 protein of the yeast transposon Ty1 can be used for constructing bifunctional virus-like particles. JMMB, 2003; 5: 97-104
29. Svirshchevskaya EV, Alekseeva L, Marchenko A et al: Immune response modulation by recombinant peptides expressed in virus-like particles. Clin Exp Immunol, 2002; 127(2): 199-205
30. Mambula SS, Sau K, Henneke P et al: Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem, 2002; 277(42): 39320-26
31. Skov M, Pressler T, Jensen HE et al: Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax, 1999; 54: 44-50
32. van Rens MT, Vernooy-Jeras R, Merton-de Ridder M et al: Detection of immunoglobulins G and A to Aspergillus fumigatus by immunoblot analysis for monitoring Aspergillus-induced lung diseases. Eur Respir J, 1998; 11: 1274-80
33. Latge JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 1999; 12: 310-50
34. Hemmann S, Nikolaizik WH, Schoni MH et al: Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol, 1998; 28: 1155-60
35. Kurup VP, Banerjee B, Hemmann S et al: Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy, 2000; 30: 988-93
36. Mari A: Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPh1 p 1, rPh1 p 2, nPh1 p 4, rPh1 p 5, rPh1 p 6, rPh1 p 7, rPh1 p 11, and rPh1 p 12: epidemiological and diagnostic data. Clin Exp Allergy, 2003; 33(1): 43-51
37. Cho Y, Basta S, Chen W et al: Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus. J Virol, 2003; 77(8): 4679-84
38. Yu XG, Addo MM, Rosenberg ES et al: Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol, 2002; 76(17): 8690-701
39. Kurup VP, Xia JQ, Crameri R et al: Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol, 2001; 98(3): 327-36